Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 57 Mesothelioma 35 Unspecified Adult Solid Tumor, Protocol Specific 25 Solid Tumor 9 Advanced Solid Tumors 8 Advanced Solid Tumor 7 Solitary Fibrous Tumor, Pleural 6 Carcinoma, Non-Small-Cell Lung 6 Sarcoma 4 Lung Neoplasms 4 Solid Tumors 3 Peritoneal Neoplasms 3 Neoplasms 3 Stomach Neoplasms 2 Retinoblastoma 2 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Head and Neck Neoplasms 2 Extensive Stage Small Cell Lung Cancer 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Central Nervous System Neoplasms 2 Breast Neoplasms 2 Advanced Solid Tumour 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

ispinesib 2 trifluridine tipiracil drug combination 1 trametinib 1 tipiracil 1 irinotecan sucrosofate 1 Vincristine 1 Trifluridine 1 Temozolomide 1 TP protocol 1 SB 743921 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Exercise Therapy 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor Cancer × Cisplatin × Other solid neoplasm × Clear all

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡